Evidence map›Paper›PMID 39451411›Full record

ArticleBioengineering (Basel, Switzerland)2024

Comparative Analysis of AI Models for Atypical Pigmented Facial Lesion Diagnosis.

Alessandra Cartocci, Alessio Luschi, Linda Tognetti, Elisa Cinotti, Francesca Farnetani, Aimilios Lallas, John Paoli, Caterina Longo, Elvira Moscarella, Danica Tiodorovic and 12 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Alessandra CartocciDermatology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-1818-6275
Alessio LuschiDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7615-9187
Linda TognettiDermatology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-6691-4310
Elisa CinottiDermatology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-4009-0659
Francesca FarnetaniDepartment of Dermatology, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Aimilios LallasFirst Department of Dermatology, Aristotle University, 541 24 Thessaloniki, Greece.ORCID 0000-0002-7193-0964
John PaoliDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.ORCID 0000-0003-1326-8535
Caterina LongoDepartment of Dermatology, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Elvira MoscarellaDermatology Unit, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
Danica TiodorovicDermatology Clinic, Medical Faculty, University of Nis, 18000 Nis, Serbia.
Ignazio StanganelliSkin Cancer Unit, Scientific Institute of Romagna for the Study of Cancer, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Romagnolo per lo Studio dei Tumori, 47014 Meldola, Italy.
Mariano SuppaDepartment of Dermatology, Hôpital Erasme, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Emi DikaOncologic Dermatology Unit, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero Universitaria Bologna, 40138 Bologna, Italy.ORCID 0000-0003-3186-2861
Iris ZalaudekDermatology Clinic, Ospedale di Trieste, 34141 Trieste, Italy.
Maria Antonietta PizzichettaDepartment of Medical Oncology, Centro di Riferimento Oncologico di Aviano, 33081 Aviano, Italy.
Jean Luc PerrotDermatology Unit, University Hospital of St-Etienne, 42270 Saint Etienne, France.ORCID 0000-0003-4479-9961
Gabriele CeveniniDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7212-573X
Ernesto IadanzaDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7291-4990
Giovanni RubegniOphthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
Harald KittlerDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-0051-8016
Philipp TschandlDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0391-7810
Pietro RubegniDermatology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7762-9312

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing atypical pigmented facial lesions (aPFLs) is a challenging topic for dermatologists. Accurate diagnosis of these lesions is crucial for effective patient management, especially in dermatology, where visual assessment plays a central role. Incorrect diagnoses can result in mismanagement, delays in appropriate interventions, and potential harm. AI, however, holds the potential to enhance diagnostic accuracy and provide reliable support to clinicians. This work aimed to evaluate and compare the effectiveness of machine learning (logistic regression of lesion features and patient metadata) and deep learning (CNN analysis of images) models in dermoscopy diagnosis and the management of aPFLs. This study involved the analysis of 1197 dermoscopic images of facial lesions excised due to suspicious and histologically confirmed malignancy, classified into seven classes (lentigo maligna-LM; lentigo maligna melanoma-LMM; atypical nevi-AN; pigmented actinic keratosis-PAK; solar lentigo-SL; seborrheic keratosis-SK; and seborrheic lichenoid keratosis-SLK). Image samples were collected through the Integrated Dermoscopy Score (iDScore) project. The statistical analysis of the dataset shows that the patients mean age was 65.5 ± 14.2, and the gender was equally distributed (580 males-48.5%; 617 females-51.5%). A total of 41.7% of the sample constituted malignant lesions (LM and LMM). Meanwhile, the benign lesions were mainly PAK (19.3%), followed by SL (22.2%), AN (10.4%), SK (4.0%), and SLK (2.3%). The lesions were mainly localised in the cheek and nose areas. A stratified analysis of the assessment provided by the enrolled dermatologists was also performed, resulting in 2445 evaluations of the 1197 images (2.1 evaluations per image on average). The physicians demonstrated higher accuracy in differentiating between malignant and benign lesions (71.2%) than in distinguishing between the seven specific diagnoses across all the images (42.9%). The logistic regression model obtained a precision of 39.1%, a sensitivity of 100%, a specificity of 33.9%, and an accuracy of 53.6% on the test set, while the CNN model showed lower sensitivity (58.2%) and higher precision (47.0%), specificity (90.8%), and accuracy (59.5%) for melanoma diagnosis. This research demonstrates how AI can enhance the diagnostic accuracy in complex dermatological cases like aPFLs by integrating AI models with clinical data and evaluating different diagnostic approaches, paving the way for more precise and scalable AI applications in dermatology, showing their critical role in improving patient management and the outcomes in dermatology.

Indexed as

convolutional neural networkdeep learningdermatoscopyiDScorelogistic regressionmachine learningpigmented facial lesionsskin cancer

Identifiers

PMID39451411
PMCPMC11504969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.